Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

8.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.8K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.1K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.1K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

7.5K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.5K
Principles of Drug Action01:24

Principles of Drug Action

6.7K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
6.7K
Drug Clearance: Overview01:06

Drug Clearance: Overview

168
Drug elimination refers to drug removal from the body, either through urine or bile, by the kidneys or liver, respectively. A pharmacokinetic parameter, drug clearance, measures the efficiency of drug removal from the bloodstream within a specific time frame. It is calculated as the rate at which a drug is eliminated from plasma divided by the drug's concentration in plasma.
Drug clearance is not limited to renal excretion but encompasses all organs involved in drug elimination, including...
168
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

663
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
663

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

GHF-ACL: A novel contrastive learning framework with multi-order graph structures for herb-disease association prediction.

PLoS computational biology·2026
Same author

Identification and characterization of lncRNA-stemness-immune regulatory patterns.

Briefings in bioinformatics·2026
Same author

Hypoxia-Associated Alternative Polyadenylation of CARM1 and Tumor Microenvironment Alterations in Non-Small Cell Lung Cancer.

Genes·2026
Same author

DECODE: deep learning-based common deconvolution framework for various omics data.

Nature methods·2026
Same author

DL-GapFilling: a novel deep learning framework for improved plant genome gap filling.

Briefings in bioinformatics·2026
Same author

Reference-Guided Chromosome-by-Chromosome de novo Assembly at Scale Using Low-Coverage High-Fidelity Long-Reads with HiFiCCL.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2025

Related Experiment Video

Updated: Sep 18, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.7K

MGPT: A Multi-task Graph Prompt Learning Framework for Drug Discovery.

Yang Li1, Youhan Sun1, Xinyu Qin1

  • 1College of Computer and Control Engineering, Northeast Forestry University, Hexing Road, Harbin, Heilongjiang, 150040, China.

Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|June 25, 2025
PubMed
Summary

A new Multi-task Graph PrompT (MGPT) model improves drug association prediction, especially with limited data. This approach offers robust graph representations for few-shot learning in drug development.

Keywords:
drug associationsheterogeneous graph networkmulti‐task prompt tuningself‐supervised contrastive learning

More Related Videos

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

5.0K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.5K

Related Experiment Videos

Last Updated: Sep 18, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.7K
Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

5.0K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.5K

Area of Science:

  • Biomedical research
  • Computational drug discovery
  • Graph representation learning

Background:

  • Accurate prediction of drug associations (drug-target, side effects, disease relationships) is vital for precision medicine.
  • Graph representation learning methods are increasingly used for drug association studies.
  • Challenges exist in applying graph pre-training to drug development, particularly for multi-task and few-shot learning.

Purpose of the Study:

  • To propose a unified Multi-task Graph PrompT (MGPT) learning model.
  • To provide generalizable and robust graph representations for few-shot drug association prediction.
  • To address challenges in multi-task learning and limited data scenarios in drug development.

Main Methods:

  • Constructed a heterogeneous graph network with entity pairs as nodes.
  • Employed self-supervised contrastive learning of sub-graphs during pre-training.
  • Utilized learnable functional prompts embedded with task-specific knowledge for downstream tasks.

Main Results:

  • Demonstrated robust performance across various drug association tasks.
  • Showcased seamless task switching capabilities.
  • Outperformed competitive approaches, particularly in few-shot learning scenarios.

Conclusions:

  • MGPT offers a robust solution for multi-task learning in drug development.
  • The model effectively addresses the challenges of limited data in drug association prediction.
  • MGPT provides generalizable graph representations crucial for advancing precision medicine.